<DOC>
	<DOCNO>NCT00246675</DOCNO>
	<brief_summary>The purpose project test whether commonly use medication frusemide , give heart surgery , aim increase urinary output effect kidney function .</brief_summary>
	<brief_title>Frusemide Infusion Prevention Deterioration Renal Function Post Cardiac Surgery .</brief_title>
	<detailed_description>All patient receive standard supportive care base current establish management practice cardio-thoracic patient . The difference treatment randomisation patient receive/not receive protocolised administration frusemide target urine output . There 2 group patient . The control group-which receive frusemide bolus dos require determine surgeon/consultant physician . The frusemide infusion group-which monitor achieve trial specify hourly urine output target range 1-2mls/kg/hour . In order achieve target patient may need receive load dose frusemide may also require frusemide infusion . The aim maintain urine output within target range first 48 hour cardiac surgery .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>All patient admit cardiac surgery assess eligibility . Participants approach inclusion , preadmission clinic ward Cardiothoracic surgery unit . Potential participant identify daily review plan cardiothoracic surgery schedule . 1 . Already establish dialysis dependent chronic renal failure . 2 . Known allergy frusemide 3 . Age &lt; 18 year 4 . Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>